FORCED DEGRADATION STUDY OF TORASEMIDE: CHARACTERIZATION OF ITS DEGRADATION PRODUCTS

REFERENCES

• Sweetman , S. Martindale, The Complete Drug Reference 36 , E-Publishing, Pharmaceutical Press : London , 2009 .
   Google Scholar
• Liu , K. ; Lee , Y. ; Ryu , J. ; Lee , D. ; Kang , W. ; Lee , S. S. ; Yoon , Y. ; Shin , J. Simple and Sensitive Assay of Torasemide in Human Plasma by High-Performance Liquid Chromatography Using a Monolithic Silica Column . Chromatographia 2004 , 60 , 639 – 643 .
   Web of Science ®Google Scholar
• Engelhardt , S. ; Meineke , I. ; Brockmöller , J. Improved Solid-Phase Extraction and HPLC Measurement of Torasemide and Its Important Metabolites . J. Chromatogr. B 2006 , 831 , 31 – 35 .
   PubMed Web of Science ®Google Scholar
• Barroso , M. B. ; Alonso , R. M. ; Jimenez , R. M. Simultaneous Determination of Torasemide and Its Major Metabolite M5 in Human Urine by High-Performance Liquid Chromatography–Electrochemical Detection . J. Chromatogr. Sci. 2001 , 39 , 491 – 496 .
   PubMed Web of Science ®Google Scholar
• Barroso , M. B. ; Meiring , H. D. ; de Jong , A. ; Alonso , R. M. ; Jimenez , R. M. Gas Chromatographic–Mass Spectrometric Analysis of the Loop Diuretic Torasemide in Human Urine . J. Chromatogr. B 1997 , 690 , 105 – 113 .
   Web of Science ®Google Scholar
• Akesolo , U. ; Gonzalez , L. ; Jimenez , R. M. ; Alonso , R. M. Multivariate Optimization of a Cyclodextrin-Assisted-Capillary Zone Electrophoretic Method for the Separation of Torasemide and Its Metabolites . J. Chromatogr. A 2003 , 990 , 271 – 279 .
   PubMed Web of Science ®Google Scholar
• Deventer , K. ; Pozzo , O. J. ; van Eenoo , P. ; Delbeke , F. T. Qualitative Detection of Diuretics and Acidic Metabolites of Other Doping Agents in Human Urine by High-Performance Liquid Chromatography–Tandem Mass Spectrometry . J. Chromatogr. A 2009 , 1216 , 5819 – 5827 .
   PubMed Web of Science ®Google Scholar
• Qin , Y. ; Wang , X. B. ; Wang , C. ; Zhao , M. ; Wu , M. T. ; Xu , Y. X. ; Peng , S. Q. Application of High-Performance Liquid Chromatography–Mass Spectrometry to Detection of Diuretics in Human Urine . J. Chromatogr. B 2003 , 794 , 193 – 203 .
   PubMed Web of Science ®Google Scholar
• Goebel , C. ; Trout , G. J. ; Kazlauskas , R. Rapid Screening Method for Diuretics in Doping Control Using Automated Solid Phase Extraction and Liquid Chromatography–Electrospray Tandem Mass Spectrometry. Anal. Chim. Acta 2004, 502, 65–74.
   Web of Science ®Google Scholar
• Marchi , I. ; Rudaz , S. ; Veuthey , J. Sample Preparation Development and Matrix Effects Evaluation for Multianalyte Determination in Urine . J. Pharm. Biomed. Anal. 2009 , 49 , 459 – 467 .
   PubMed Web of Science ®Google Scholar
• Thieme , D. ; Grosse , J. ; Lang , R. ; Mueller , R. K.; Wahl A. Screening, Confirmation and Quantitation of Diuretics in Urine for Doping Control Analysis by High-Performance Liquid Chromatography–Atmospheric Pressure Ionization Tandem Mass Spectrometry . J. Chromatogr. B 2001 , 757 , 49 – 57 .
   Web of Science ®Google Scholar
• Deventer , K. ; van Eenoo , P. ; Delbeke , F. T. Simultaneous Determination of Beta-Blocking Agents and Diuretics in Doping Analysis by Liquid Chromatography/Mass Spectrometry with Scan to Scan Polarity Switching . Rapid Commun. Mass Spectrom. 2005 , 19 , 90 – 98 .
   PubMed Web of Science ®Google Scholar
• Riekkola , M. ; Jumppanen , J. H. Capillary Electrophoresis of Diuretics . J. Chromatogr. A 1996 , 735 , 151 – 164 .
   PubMed Web of Science ®Google Scholar
• The United States Pharmacopeia 31 . United States Pharmacopeial Convention : Rockville , MD , USA , 2007 .
   Google Scholar
• British Pharmacopoeia 2009 . The Stationery Office : London , UK , 2008 .
   Google Scholar
• European Pharmacopoeia 7th ed. Council of Europe : Strasbourg , 2011 .
   Google Scholar
• Patel , H. B. ; Mohan , A. ; Joshi , H. S. Reversed-Phase Ultra-Performance Liquid Chromatographic Method Development and Validation for Determination of Impurities Related to Torsemide Tablets . J. AOAC Int. 2011 , 94 , 143 – 149 .
   PubMed Web of Science ®Google Scholar
• ICH Q1A (R2) . Fed. Regist. 2003 , 68 , 65717 – 65718 .
   PubMedGoogle Scholar
• ICH Q1B. Fed. Regist. 1997 , 62 , 27115 – 27122 .
   Google Scholar
• Jovic , Z. ; Zivanovic , Lj. ; Radisic , M. ; Protic , A. ; Malesevic , M. Chemometrically Assisted Development and Validation of LC/UV and LC/MS Methods for Simultaneous Determination of Torasemide and Its Impurities . J. Chromatogr. Sci. 2012 , 50 , 324 – 334 .
   PubMed Web of Science ®Google Scholar
• Huynh-Ba , K. Handbook of Stability Testing in Pharmaceutical Development , Springer Science : New York , 2009 .
   Google Scholar
• Alsante , K. M. ; Ando , A. ; Brown , R. ; Ensing , J. ; Hatajik , T. D. ; Kong , W. ; Tsuda , Y. The Role of Degradant Profiling in Active Pharmaceutical Ingredients and Drug Products . Adv. Drug Deliv. Rev. 2007 , 59 , 29 – 37 .
   PubMed Web of Science ®Google Scholar
• Kondo , N. ; Kimura , M. ; Yamamoto , M. ; Hashimoto , H. ; Kawamata , K. ; Kawano , K. ; Schmidt , H. Chemical Structure and Physico-Chemical Properties of Torasemide . Iyakuhin Kenkyu 1994 , 25 , 734 – 749 .
   Google Scholar
• Baertschi , S. W. Pharmaceutical Stress Testing, Predicting Drug Degradation , Taylor & Francis Group : Boca Raton , FL , 2005 .
   Google Scholar
• ICH Q2 (R1). Addendum Incorporated 2005 . Fed. Regist. 1997 , 62 , 27463 – 27467 .
   Google Scholar